Results 171 to 180 of about 8,618 (210)
Some of the next articles are maybe not open access.
3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists
Bioorganic & Medicinal Chemistry Letters, 2005Novel 3-thio-1,2,4-triazoles have been obtained via a solution-phase parallel synthesis strategy, affording potent non-peptidic human somatostatin receptor subtypes 2 and 5 agonists.
Marie-Odile, Contour-Galcéra +3 more
openaire +2 more sources
Somatostatin receptors (sst2) regulate cGMP production in rat retina
Regulatory Peptides, 2006The present study investigated the effect of somatostatin in the regulation of cGMP levels in rat retina and the mechanisms involved in this process. Isolated rat retinas were treated alone or in the presence of somatostatin (0.01-10 microM), BIM23014 (sst2 agonist, 0.01-10 microM), L-796,778 (sst3 agonist, 10 microM), somatostatin (0.1 microM) in ...
Niki, Mastrodimou +4 more
openaire +2 more sources
Interleukin-33/sST2: Dynamic assessment in patients with acute coronary syndrome
Advances in Medical Sciences, 2023Interleukin (IL)-33 and its soluble receptor ST2 (sST2) play a crucial role in the immune response. sST2 has been approved by the Food and Drug Administration as a prognostic biomarker of mortality in chronic heart failure patients, however, the role of IL-33 and sST2 in atherosclerotic cardiovascular disease remains unclear.
Anna Witkowska +5 more
openaire +2 more sources
sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation
Molecular Biology Reports, 2021Genotyping of ST2 and galectin-3 in atrial fibrillation (AF) is not well analyzed. The aim of our study was to analyze the possible relationship between levels of sST2 and galectin-3 and three polymorphisms in patients with AF. We included 125 patients with persistent AF undergoing electric cardioversion.
Ruth Saez-Maleta +8 more
openaire +2 more sources
Dosage du récepteur soluble sST2 : perspectives
Revue Francophone des Laboratoires, 2017Resume L’insuffisance cardiaque (IC) est un probleme majeur pour nos societes contemporaines tant en termes de prevalence, de mortalite et de cout. Les peptides natriuretiques sont des biomarqueurs reconnus pour l’aide au diagnostic d’IC mais aussi pour la stratification du risque des patients.
openaire +1 more source
Role of Sst2 in Modulating G Protein-Coupled Receptor Signaling
Biochemical and Biophysical Research Communications, 1996Sst2 formally acts as an inhibitor of G protein-coupled receptor signaling in yeast perhaps stabilizing a G protein/unactivated receptor complex. desTrp1,Ala3 alpha-factor (dTA-alpha f), normally a competitive antagonist, activated responses in an sst2 strain.
A, Shah, L, Marsh
openaire +2 more sources
Biomarkers, 2020
Purpose This study examined sST2, GDF-15, and galectin-3 as indicators of disease severity and therapy response in chronic thromboembolic pulmonary hypertension (CTEPH).
S. Kriechbaum +14 more
semanticscholar +1 more source
Purpose This study examined sST2, GDF-15, and galectin-3 as indicators of disease severity and therapy response in chronic thromboembolic pulmonary hypertension (CTEPH).
S. Kriechbaum +14 more
semanticscholar +1 more source
The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.
Molecular and Cellular Endocrinology, 2021Pancreatic neuroendocrine tumors (Pan-NETs), are heterogeneous neoplasms, whose incidence and prevalence are increasing worldwide. Pan-NETs are characterized by the expression of somatostatin receptors (SSTs).
E. Vitali +7 more
semanticscholar +1 more source
Soluble ST2 (sST2) as potential marker for hepatic cystic echinococcosis activity
Journal of Infection, 2020this study aims to identify the potential marker for hepatic cystic echinococcosis (CE) activity.totally 97 CE patients and 47 health control (HC) subjects were included. Based on the ultrasound (US) images, CE patients were further categorized as active CE (ACE; 52 cases) and inactive CE (IACE; 45 cases).
Mengting, An +9 more
openaire +2 more sources
Inflammation, 2019
Interleukin 33 (IL-33) is an alarmin with multiple roles in immunity and cell homeostasis, highly expressed in barrier sites, acting via the suppression of tumorigenicity 2 receptor (ST2). Production of IL-33 and soluble ST2 (sST2), a decoy receptor for IL-33, has been implicated in several pulmonary diseases, but both have been scarcely investigated ...
Ourania S, Kotsiou +5 more
openaire +2 more sources
Interleukin 33 (IL-33) is an alarmin with multiple roles in immunity and cell homeostasis, highly expressed in barrier sites, acting via the suppression of tumorigenicity 2 receptor (ST2). Production of IL-33 and soluble ST2 (sST2), a decoy receptor for IL-33, has been implicated in several pulmonary diseases, but both have been scarcely investigated ...
Ourania S, Kotsiou +5 more
openaire +2 more sources

